Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma
- 21 June 2018
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (9) , 2373-2380
Abstract
Circulating tumors cells (CTCs) may be a promising prognostic marker for patients with malignant tumors. However, there are few reports regarding its value for hepatocellular carcinoma (HCC) patients.Keywords
This publication has 33 references indexed in Scilit:
- Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of diseaseCell Death & Disease, 2013
- Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patientsBreast Cancer Research, 2011
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasisClinical & Experimental Metastasis, 2009
- Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary resultJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survivalJournal of Cancer Research and Clinical Oncology, 2005
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literatureJournal of Cancer Research and Clinical Oncology, 2004